Screener
Amphastar Pharmaceuticals AMPH Goodwill
Goodwill at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsNetIncludingGoodwill.
The source filing: Amphastar Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:50 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001297184-26-000047
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Property, plant, and equipment, net | 316,063 | 310,567 |
| Finance lease right-of-use assets | 152 | 221 |
| Operating lease right-of-use assets | 72,911 | 42,931 |
| Goodwill and intangible assets, net | 647,833 | 565,965 |
| Other assets | 33,392 | 31,135 |
| Deferred tax assets | 42,464 | 42,464 |
| Total assets | $1,743,766 | $1,629,299 |
| LIABILITIES AND STOCKHOLDERS' EQUITY |
Item 1. Financial Statements (unaudited)
FAQ
- What is Amphastar Pharmaceuticals's goodwill?
- Amphastar Pharmaceuticals (AMPH) reported goodwill of $647.83M in Q2 2026.
- How has Amphastar Pharmaceuticals's goodwill changed year-over-year?
- Amphastar Pharmaceuticals's goodwill increased by 12.0% year-over-year, from $578.5M to $647.83M.
- What is the long-term trend for Amphastar Pharmaceuticals's goodwill?
- Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's goodwill has grown at a 69.4% compound annual growth rate (CAGR), from $40.62M to $565.97M.
- What does goodwill mean?
- The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.
Ask your AI about Amphastar Pharmaceuticals's goodwill.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude